November 1, 2021
LianBio Announces Pricing of Initial Public Offering
SHANGHAI, China and PRINCETON, N.J., Oct. 31, 2021 (GLOBE NEWSWIRE) — LianBio, a biotechnology company dedicated to bringing innovative medicines…
Pharmaceuticals, Biotechnology and Life Sciences
SHANGHAI, China and PRINCETON, N.J., Oct. 31, 2021 (GLOBE NEWSWIRE) — LianBio, a biotechnology company dedicated to bringing innovative medicines…
Orphazyme A/SCompany announcement No. 24/2021Inside informationCompany Registration No. 32266355 Progress made in understanding potential resolution of topics outlined in Complete Response…
WOBURN, MA. , Oct. 28, 2021 (GLOBE NEWSWIRE) — Biofrontera Inc. (“Biofrontera” or the “Company”) (Nasdaq: BFRI; BFRIW), a biopharmaceutical…
EMERYVILLE, Calif., Oct. 28, 2021 (GLOBE NEWSWIRE) — 4D Molecular Therapeutics, Inc. (Nasdaq: FDMT), a clinical-stage gene therapy company harnessing…
FLORHAM PARK, N.J., Oct. 27, 2021 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused…
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Oct. 28, 2021 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM;…
ROCKVILLE, Md., Oct. 27, 2021 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and…
TORONTO, Oct. 27, 2021 (GLOBE NEWSWIRE) — PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a clinical-stage…
– All Stockholder Proposals Were Approved – – Transaction Expected to Close Early November – AMITYVILLE, N.Y., Oct. 27, 2021…
SALT LAKE CITY, Oct. 27, 2021 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and…